Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

CytomX Therapeutics $75 million at-the-market offering
Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by CytomX Therapeutics, Inc. of its common stock for up to an aggregate amount of $75 million…
Black Hills $100 million equity issuance
Davis Polk advised the underwriter in connection with a $100 million SEC-registered underwritten primary block trade of 1,222,942 common shares of Black Hills Corporation. The common shares…
GAIN Capital acquisition by INTL FCStone
Davis Polk is advising Gain Capital Holdings, Inc. on its acquisition by INTL FCStone Inc. for $6.00 per share in cash. The transaction is expected to close in mid-2020, subject to approval…
JPMorgan Chase €1.25 billion notes offering
Davis Polk advised JPMorgan Chase & Co. as special U.S. counsel in connection with the offering of €1.25 billion aggregate principal amount of its fixed-to-floating rate notes due 2028…
W.W. Grainger $500 million notes offering
Davis Polk advised the underwriters on an SEC-registered offering by W.W. Grainger of $500 million aggregate principal amount of 1.85% senior notes due 2025. Headquartered in Lake Forest,…
Citrix $750 million notes offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by Citrix Systems, Inc. of $750 million aggregate principal amount of its 3.300% senior notes due 2030…
Back to top